Literature DB >> 25359602

The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death.

Igor Buchwalow1, Werner Boecker, Markus Tiemann.   

Abstract

Paul Ehrlich is the founder of a number of areas in biomedical research: in the first line, immunology and chemotherapy. Aim of this historical note to the centenary of Paul Ehrlich's death is to commemorate his tribute to the establishment and development of histochemistry.

Entities:  

Mesh：

Year:  2014        PMID： 25359602     DOI： 10.1007/s00428-014-1677-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


  9 in total

1.  Paul Ehrlich: pathfinder in cell biology. 1. Chronicle of his life and accomplishments in immunology, cancer research, and chemotherapy.

Authors:  F H Kasten
Journal:  Biotech Histochem       Date:  1996-01       Impact factor: 1.718

2.  Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells.

Authors:  Enrico Crivellato; Carlo alberto Beltrami; Franco Mallardi; Domenico Ribatti
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

3.  Paul Ehrlich: founder of chemotherapy.

Authors:  Stefan H E Kaufmann
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

4.  Domagk and the development of the sulphonamides.

Authors:  H Otten
Journal:  J Antimicrob Chemother       Date:  1986-06       Impact factor: 5.790

5.  The history of the Ziehl-Neelsen stain.

Authors:  P J Bishop; G Neumann
Journal:  Tubercle       Date:  1970-06

Review 6.  The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize.

Authors:  Fèlix Bosch; Laia Rosich
Journal:  Pharmacology       Date:  2008-08-05       Impact factor: 2.547

7.  Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.

Authors:  Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Journal:  Malar J       Date:  2006-10-08       Impact factor: 2.979

8.  Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept.

Authors:  Cay-Rüdiger Prüll
Journal:  Med Hist       Date:  2003-07       Impact factor: 1.419

9.  Paul Ehrlich as a commercial scientist and research administrator.

Authors:  J Liebenau
Journal:  Med Hist       Date:  1990-01       Impact factor: 1.419
  9 in total
  6 in total

Review 1.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

2.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2018-05-04       Impact factor: 4.304

3.  Characterization of mast cell populations using different methods for their identification.

Authors:  Dmitri Atiakshin; Vera Samoilova; Igor Buchwalow; Werner Boecker; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2017-02-27       Impact factor: 4.304

Review 4.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

5.  Evaluation of New Immunohistochemical Approaches for the Study of Kidney Tumors in Geriatric.

Authors:  T V Pavlova; N B Pilkevich; D V Bessmertnyi; I A Pavlov; D V Atiakshin; L A Pavlova
Journal:  Arch Razi Inst       Date:  2021-10-31

Review 6.  Immunohistochemistry as a detection tool for ion channels involved in dental pain signaling.

Authors:  Rosmaliza Ramli; Siti Norasikin Mohd Nafi; Nor Azura Ahmad Tarmidzi; Nurulezah Hasbullah; Nurhafizah Ghani
Journal:  Saudi Dent J       Date:  2022-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.